Developing Evidence to Inform Decisions about Effectiveness Research Network-2 (DEcIDE-2)

This program is supported by the Agency for Healthcare Research and Quality (AHRQ) to assist AHRQ and other Federal Agencies with patient-centered outcomes research, including studies on comparative clinical effectiveness as authorized by Section 1013 of the Medicare Modernization Act of 2003 (MMA) and subsequent legislation such as the American Recovery and Reinvestment Act (ARRA). The Decisions about Effectiveness Research Network-2 (DEcIDE-2)  will continue to provide a variety of research services and scientific products to support the generation of new scientific evidence on patient-centered outcomes of healthcare items and services, with a focus on comparative clinical effectiveness research. Activities performed by the DEcIDE Research Network reflect the general principle that clinicians and patients should have the best available scientific evidence upon which to make individual decisions about health care items and services. Notably, a hallmark of the DEcIDE Research Network program is to provide high quality research that contributes to the evidence base and serves to inform healthcare decision-making. Hence, the DEcIDE Research Network program will continue its focus on original research that generates objective scientific evidence and new analytic tools for assisting patients, clinicians, purchasers, policy-makers, and others in making informed health care decisions. NOTE: None of the task orders awarded under the IDIQ contracts will be subject to ARRA funding and reporting requirements. Major activities a DEcIDE-2 research center may perform. 1. Conduct multi-center prospective observational and interventional studies. 2. Analyze, link, and develop electronic health data for research. 3. Perform retrospective analytical studies to inform and support research as well as research prioritization and decision-making. 4. Develop and apply new research methods, instruments, and methodologies. 5. Provide technical assistance to AHRQ and other assignments as requested.


Principal Investigator: Til Stürmer, MD, PhD

Funding: AHRQ

Total Project Period: 07/26/2010 – 07/24/2013